The Outlook for BRAF Inhibitors in Melanoma

December 18, 2013
Antoni Ribas, MD, PhD

Special Reports, Melanoma (Issue 1), Volume 1, Issue 1

Antoni Ribas, MD, PhD, professor of medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, discusses the outlook for BRAF inhibitors in melanoma.

Antoni Ribas, MD, PhD, professor of medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, discusses the outlook for BRAF inhibitors in melanoma.

Read more about BRAF inhibitors for the treatment of melanoma andadvances in metastatic disease